World's Best Scientists 2026 revealed!
Ingo G.H. Schmidt-Wolf

Ingo G.H. Schmidt-Wolf

D-Index & Metrics

Medicine

D-Index
78
Citations
27283
World Ranking
17894
National Ranking
940

Ingo G.H. Schmidt-Wolf publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ingo G.H. Schmidt-Wolf sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 379 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ingo G.H. Schmidt-Wolf D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ingo G.H. Schmidt-Wolf sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ingo G.H. Schmidt-Wolf is affiliated with the University Hospital Bonn in Germany. Their research spans multiple areas within medicine, particularly focusing on oncology, molecular biology, and immunology. Their work is also connected with cancer research and pulmonary and respiratory medicine as significant subfields of their study.

The scientist has contributed extensively to the understanding of immune cell function and interaction, CAR-T cell therapy research, and cancer immunotherapy and biomarkers. Other main topics in their research include cancer-related molecular mechanisms, histone deacetylase inhibitors, immunotherapy and immune responses, and extracellular vesicles in disease.

Frequent co-authors in Schmidt-Wolf's research include Amit Sharma, Miroslaw Kornek, Maria A. González-Carmona, Yulu Wang, and Christian P. Strassburg.

Their publications often appear in reputable journals, with repeated contributions in venues such as:

  • Cancers
  • Frontiers in Immunology
  • Cancer Immunology Immunotherapy
  • Frontiers in Oncology
  • Scientific Reports

Selected recent papers include:

  • Ten-year update of the international registry on cytokine-induced killer cells in cancer immunotherapy, 2020, Journal of Cellular Physiology
  • Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome, 2020, BMC Cancer
  • Oncogenes and tumor suppressor genes: functions and roles in cancers, 2024, MedComm
  • 30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective, 2021, Journal of Experimental & Clinical Cancer Research
  • Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives, 2024, Experimental Hematology and Oncology

The main fields of study where Schmidt-Wolf has published include Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. Their multidisciplinary approach combines expertise in oncology and molecular biology with a strong focus on immune mechanisms relevant to cancer therapy.

Best Publications

  • Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

    Gary Hudes;Michael Carducci;Piotr Tomczak;Janice Dutcher

  • Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

    Helmut Oettle;Stefan Post;Peter Neuhaus;Klaus Gellert

  • Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

    Pieter Sonneveld;Ingo G.H. Schmidt-Wolf;Bronno Van Der Holt;Laila El Jarari

  • Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

    Hendrik Pels;Ingo G.H. Schmidt-Wolf;Axel Glasmacher;Holger Schulz

  • Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study

    Anjali Advani;Bertrand Coiffier;Myron S. Czuczman;Martin Dreyling

  • Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p

    Kai Neben;Henk M. Lokhorst;Anna Jauch;Uta Bertsch

  • RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group

    Verena I. Gaidzik;Lars Bullinger;Richard F. Schlenk;Andreas S. Zimmermann

  • Itraconazole Prevents Invasive Fungal Infections in Neutropenic Patients Treated for Hematologic Malignancies: Evidence From a Meta-Analysis of 3,597 Patients

    Axel Glasmacher;Archibald Prentice;Marcus Gorschlüter;Steffen Engelhart

  • Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial.

    Angela Märten;Dimitri Flieger;Sabine Renoth;Silvia Weineck

  • Non-viral and hybrid vectors in human gene therapy: an update

    Gabriele D Schmidt-Wolf;Ingo G.H Schmidt-Wolf

  • High EVI1 Expression Predicts Outcome in Younger Adult Patients With Acute Myeloid Leukemia and Is Associated With Distinct Cytogenetic Abnormalities

    Stefan Gröschel;Sanne Lugthart;Richard F. Schlenk;Peter J.M. Valk

  • A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma.

    Axel Glasmacher;Corinna Hahn;Florian Hoffmann;Ralph Naumann

  • Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations.

    Märten A;Ziske C;Schöttker B;Renoth S

  • Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial

    Dieter Hoelzer;Jan Walewski;Hartmut Döhner;Andreas Viardot

  • Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial.

    Burghardt Wittig;Angela Märten;Tomislav Dorbic;Silvia Weineck

  • Clinical Trials on CIK Cells: First Report of the International Registry on CIK Cells (IRCC)

    C. Hontscha;Y. Borck;H. Zhou;D. Messmer

  • Neutropenic enterocolitis in adults: systematic analysis of evidence quality.

    Marcus Gorschlüter;Ulrich Mey;John Strehl;Carsten Ziske

  • Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine

    C Ziske;C Schlie;M Gorschlüter;A Glasmacher

  • Mechanism of Cytotoxicity Induced by Chimeric Mouse Human Monoclonal Antibody IDEC-C2B8 in CD20-Expressing Lymphoma Cell Lines

    Dimitri Flieger;Sabine Renoth;Imke Beier;Tilman Sauerbruch

  • Repeated Bone-Targeted Therapy for Hormone-Refractory Prostate Carcinoma: Randomized Phase II Trial With the New, High-Energy Radiopharmaceutical Rhenium-188 Hydroxyethylidenediphosphonate

    Holger Palmedo;Agnieska Manka-Waluch;Peter Albers;Ingo G.H. Schmidt-Wolf

Frequent Co-Authors

Tilman Sauerbruch
Tilman Sauerbruch University of Bonn
Hartmut Goldschmidt
Hartmut Goldschmidt University Hospital Heidelberg
Anna Jauch
Anna Jauch Heidelberg University
Burghardt Wittig
Burghardt Wittig Freie Universität Berlin
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Christian P. Strassburg
Christian P. Strassburg University Hospital Bonn
Anthony D. Ho
Anthony D. Ho University Hospital Heidelberg
Andreas Engert
Andreas Engert University of Cologne
Peter Brossart
Peter Brossart University Hospital Bonn
Hartmut Döhner
Hartmut Döhner University of Ulm

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine can open doors to a range of rewarding online degrees. For those seeking administrative roles in healthcare, online health administration programs offer a fast and flexible route to management positions, even for working professionals.

If you already hold an associate degree in nursing, asn to fnp bridge paths are available online, enabling registered nurses to become Family Nurse Practitioners through streamlined study.

Specialized tracks like the online bachelor's in nutrition provide a focused curriculum for careers in dietetics, wellness, and public health. This pathway is ideal for students passionate about preventive medicine and healthy living.

For those seeking accredited leadership degrees, pursuing online mha programs ensures you're learning within CAHME standards — highly valued across hospitals and healthcare systems.

Online degrees increase accessibility, allowing you to balance study with work or family life. They're a strong choice for individuals mapping diverse career pathways in the healthcare field.

Best Scientists Citing Ingo G.H. Schmidt-Wolf

Trending Scientists

Recently Published Articles